Log in
Enquire now
‌

US Patent 9303029 Substituted quinoxalines as FGFR kinase inhibitors

Patent 9303029 was granted and assigned to Astex Therapeutics Limited on April, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9303029 Substituted quinoxalines as FGFR kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.